TAOK3 and metabolic dysfunction-associated steatotic liver disease: Our study emphasizes the importance of lipid droplet-binding proteins in the control of intrahepatocellular fat storage and highlights the inhibition of lipid droplet decorating STE20-type kinase TAOK3 as a potential NAFLD therapy via antagonizing hepatic steatosis.